Why is Globus Medical, Inc. ?
1
Company has a low Debt to Equity ratio (avg) at times
2
Low Debt Company with Strong Long Term Fundamental Strength
3
The company has declared Positive results for the last 3 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 669.15 MM
- NET PROFIT(Q) Highest at USD 252.97 MM
- RAW MATERIAL COST(Y) Fallen by -16.19% (YoY)
4
With ROE of 5.54%, it has a expensive valuation with a 1.98 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 7.16%, its profits have risen by 69.2% ; the PEG ratio of the company is 0.5
How much should you buy?
- Overall Portfolio exposure to Globus Medical, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Globus Medical, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Globus Medical, Inc.
38.1%
0.64
53.51%
S&P 500
25.41%
0.70
20.15%
Quality key factors
Factor
Value
Sales Growth (5y)
30.08%
EBIT Growth (5y)
31.06%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.11
Sales to Capital Employed (avg)
0.51
Tax Ratio
20.34%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
12.35%
ROE (avg)
7.98%
Valuation Key Factors 
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
2.47
EV to EBIT
19.92
EV to EBITDA
13.17
EV to Capital Employed
2.67
EV to Sales
3.67
PEG Ratio
0.08
Dividend Yield
NA
ROCE (Latest)
13.41%
ROE (Latest)
13.01%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Movement
15What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 778.51 MM
NET PROFIT(HY)
At USD 283.52 MM has Grown at 114.39%
ROCE(HY)
Highest at 13.3%
RAW MATERIAL COST(Y)
Fallen by -4.88% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -10.86 %
INVENTORY TURNOVER RATIO(HY)
Highest at 1.55 times
OPERATING PROFIT MARGIN(Q)
Highest at 30.72 %
-2What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Globus Medical, Inc.
Net Profit
At USD 283.52 MM has Grown at 114.39%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD 778.51 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Operating Profit Margin
Highest at 30.72 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Debt-Equity Ratio
Lowest at -10.86 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 1.55 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -4.88% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales






